Today: 18 January 2026
Subscribe
Browse Category

Investment Outlook News 9 December 2025 - 14 December 2025

Novo Nordisk Stock (NOVO-B, NVO) Update Dec 14, 2025: Wegovy 7.2 mg Tailwind, Ozempic India Launch, Akero Deal — Outlook for the Week Ahead

Novo Nordisk Stock (NOVO-B, NVO) Update Dec 14, 2025: Wegovy 7.2 mg Tailwind, Ozempic India Launch, Akero Deal — Outlook for the Week Ahead

Updated: December 14, 2025 (Sunday) Novo Nordisk A/S shares ended this week with a rebound after a choppy start, as investors weighed three heavyweight catalysts: (1) the EU regulator’s support for a higher-dose Wegovy, (2) the long-telegraphed India launch of Ozempic at a sharply lower price point, and (3) the closing of Novo’s multibillion-dollar acquisition of Akero Therapeutics to expand…
14 December 2025
····
ANZ Group Holdings (ASX: ANZ) Stock: This Week’s Key Catalysts, Dividend, AGM Pay Vote — and the Week-Ahead Outlook (Updated 14 Dec 2025)

ANZ Group Holdings (ASX: ANZ) Stock: This Week’s Key Catalysts, Dividend, AGM Pay Vote — and the Week-Ahead Outlook (Updated 14 Dec 2025)

Updated: 14 December 2025 (AEST)ANZ Group Holdings Limited (ASX: ANZ) heads into the final full trading week before Christmas with its share price steady, its final dividend payment days away, and its Annual General Meeting (AGM) shaping up as a major governance flashpoint. As of the last ASX close on Friday, 12 December 2025, ANZ finished at A$35.81, around 8%…
14 December 2025
··
CRH PLC Stock News Today (Dec. 12, 2025): Buyback Update, S&P 500 Inclusion, Analyst Forecasts and 2026 Outlook for NYSE:CRH

CRH PLC Stock News Today (Dec. 12, 2025): Buyback Update, S&P 500 Inclusion, Analyst Forecasts and 2026 Outlook for NYSE:CRH

CRH plc (NYSE: CRH) is back in the spotlight on Friday, December 12, 2025, as investors weigh a fresh share buyback disclosure alongside a major near-term catalyst: CRH’s scheduled addition to the S&P 500 later this month. Add in upbeat 2025 guidance, margin expansion, and a steady drumbeat of analyst updates, and CRH stock is shaping up as one of…
12 December 2025
···
UOB Stock (SGX: U11) Today, Dec 12, 2025: Share Price Jumps, Analyst Targets, Dividend Yield, and the 2026 Outlook

UOB Stock (SGX: U11) Today, Dec 12, 2025: Share Price Jumps, Analyst Targets, Dividend Yield, and the 2026 Outlook

United Overseas Bank Limited (UOB) stock (SGX: U11 / U11.SI) rose on Dec 12, 2025 as investors weighed rate-cut tailwinds, UOB’s margin guidance, and broker forecasts. Here’s the latest price action, news, dividend picture, and what analysts expect next. United Overseas Bank Limited (UOB) shares pushed higher on Friday, December 12, 2025, extending a modest uplift seen across Singapore’s banking…
12 December 2025
···
Santos Limited Stock (ASX:STO): Share Price Snapshot, Barossa LNG Progress, Analyst Forecasts and 2026 Outlook (December 12, 2025)

Santos Limited Stock (ASX:STO): Share Price Snapshot, Barossa LNG Progress, Analyst Forecasts and 2026 Outlook (December 12, 2025)

Santos Limited stock (ASX:STO) is in focus on December 12, 2025 as investors weigh Barossa LNG execution, Australian gas policy risk, dividend and free-cash-flow outlook, and a mixed broker forecast picture. Santos Limited stock is ending 2025 with that familiar energy-market cocktail: big projects, big politics, and big expectations—all while the share price tries to decide whether it’s a bargain,…
12 December 2025
···
Opendoor Stock (OPEN) Premarket Today: Meme Rally Meets ‘Opendoor 2.0’ Reset and 2026 Forecasts

Opendoor Stock (OPEN) Premarket Today: Meme Rally Meets ‘Opendoor 2.0’ Reset and 2026 Forecasts

Updated Thursday, December 11, 2025 – around 6:30 a.m. EST Opendoor Technologies (NASDAQ: OPEN) is waking up slightly green in early trading after another volatile week that has kept the 2025 meme darling under intense scrutiny. As of about 6:30 a.m. EST, Opendoor is trading around $7.05 in premarket, roughly 0.7% above Wednesday’s close of $7.00, with early extended‑hours trades…
11 December 2025
·
GSK Stock (LON:GSK, NYSE:GSK): Latest News, FDA Catalysts and 2026 Outlook – December 11, 2025

GSK Stock (LON:GSK, NYSE:GSK): Latest News, FDA Catalysts and 2026 Outlook – December 11, 2025

GSK plc stock has quietly morphed from a problem child of Big Pharma into one of 2025’s more interesting “value with growth” stories. The shares are trading near multi‑year highs, the company has upgraded guidance, big litigation overhangs are easing, and a cluster of U.S. FDA decisions is about to test how much of that optimism is justified. As of…
11 December 2025
···
Telstra (ASX:TLS) Share Price, Dividend and Outlook: What Investors Need to Know on 11 December 2025

Telstra (ASX:TLS) Share Price, Dividend and Outlook: What Investors Need to Know on 11 December 2025

Published: 11 December 2025 Telstra Group Limited (ASX:TLS) remains one of the most closely watched stocks on the ASX 200, sitting at the crossroads of three big themes: defensive income, digital infrastructure, and an increasingly heavy regulatory spotlight. As of Thursday, 11 December 2025, Telstra’s share price is trading around A$4.89–4.90, leaving the stock roughly 21% higher year to date,…
11 December 2025
··
Dow 30 Soars Back Above 48,000 After Fed’s Third 2025 Rate Cut: December 10 Market Close & 2026 Outlook

Dow 30 Soars Back Above 48,000 After Fed’s Third 2025 Rate Cut: December 10 Market Close & 2026 Outlook

The Dow Jones Industrial Average roared higher on Wednesday, December 10, as Wall Street cheered a widely expected interest‑rate cut from the Federal Reserve and a signal that the pace of easing is likely to slow from here. By the closing bell, the Dow 30 was up roughly 500 points, or just over 1%, to about 48,058, reclaiming the 48,000…
10 December 2025
····
MercadoLibre (MELI) Stock Today: Latest News, Q3 2025 Results, Analyst Forecasts and Outlook as of December 9, 2025

MercadoLibre (MELI) Stock Today: Latest News, Q3 2025 Results, Analyst Forecasts and Outlook as of December 9, 2025

MercadoLibre, Inc. (NASDAQ: MELI), Latin America’s leading e‑commerce and fintech platform, is ending 2025 in a curious position: business momentum remains extremely strong, but the stock has cooled after hitting record highs in June. As of December 9, 2025, MercadoLibre’s share price trades around $2,060–2,080 per share, implying a market capitalization of roughly $105 billion and a trailing P/E ratio…
9 December 2025
···
NextEra Energy (NEE) Stock: AI Data Center Boom and 8% EPS Growth Target Power December 2025 Outlook

NextEra Energy (NEE) Stock: AI Data Center Boom and 8% EPS Growth Target Power December 2025 Outlook

As of the evening of December 9, 2025, NextEra Energy, Inc. (NYSE: NEE) is trading around $80.04 per share, down slightly on the day after a sharp burst of news about AI data center deals, new grid projects, and a refreshed long‑term earnings roadmap. Reuters Across just a couple of days, the company has: At the same time, Wall Street…
9 December 2025
···
ANZ Share Price on 9 December 2025: Dividend, Restructuring and Outlook for 2026

ANZ Share Price on 9 December 2025: Dividend, Restructuring and Outlook for 2026

Sydney – 9 December 2025 ANZ Group Holdings Limited (ASX: ANZ) shares are trading near the top of their 52‑week range after a year in which profits fell, regulatory costs surged and a new chief executive launched an aggressive overhaul of the bank. As of early afternoon on 9 December 2025, ANZ shares were changing hands at about A$35.12 on…
9 December 2025
···
1 2 3 4

Stock Market Today

  • Delta Air Lines stock uptrend aided by strong ROE and earnings growth
    January 18, 2026, 11:14 AM EST. Delta Air Lines has risen about 14% over the past three months as investors weigh profitability and growth prospects. The carrier reports a trailing twelve-month ROE of 24% as of December 2025, well above the industry average of 9.5%. Net income growth has run about 69% over five years, outpacing the sector's 57%. The company retains roughly 93% of earnings, with a three-year median payout ratio of 6.6%, funding reinvestment while it has maintained a long-standing dividend history. The mix of high ROE, strong retention, and a long dividend history argues for upside, though investors will judge whether prices reflect future earnings.
Go toTop